Laurus Labs shares climb 4% after Q2 profit zooms 126% YoYLaurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-ye...
30 Oct, 2026, 10.31 AM IST
Buy Laurus Labs, target price Rs 710: Bajaj BrokingBajaj Broking recommends buying Laurus Labs with a target price of Rs 710. The current price is Rs 565.4. Laurus Labs expects significant g...
27 Dec, 2024, 09.31 AM IST
Laurus Labs opens new R&D facility in IKP Knowledge Park, HyderabadLaurus Labs has inaugurated a new R&D facility at IKP Knowledge Park near Hyderabad, investing Rs 250 crore. The 200,000 square foot center...
16 Sep, 2024, 03.09 PM IST
Laurus Labs invests Rs 80 crore in cell & gene therapy firm ImmunoACTThe fresh infusion of capital will enable ImmunoACT to fast-track the scale-up of its lead candidate HCAR-19 by expansion of the multi-loca...
31 May, 2023, 08.22 PM IST
Laurus Labs net profit rises 15% to Rs 233 crore in Q2FY23The company had reported a net profit of Rs 202 crore during the same period of the previous year. On a quarter-on-quarter (QoQ) basis , th...
21 Oct, 2022, 04.55 PM IST
Laurus Labs posts Rs 251 crore net profit in Q1FY23The company attributed this to the change in the effective tax rate for Q1FY23 on account of a drop in SEZ profits exemption u/s 10AA to 50...
27 Jul, 2022, 06.54 PM IST
Laurus Labs will try to make ‘rare’ drugs affordable in India: CEO“We want to bring the drugs which are not available in India. The biggest factor is affordability. If you bring a medicine which is not aff...
03 May, 2022, 01.03 AM IST
ET Emerging Company of the Year 2021: Laurus Labs-A pharma company beats the virus trap to make it bigIt supplies active pharmaceutical ingredients (APIs) to nine out of the 10 largest generic pharma companies and has leadership positions in...
29 Mar, 2022, 10.29 AM IST
Laurus Labs Q3 results: Net profit drops 44% YoY to Rs 154 croreThe earnings before interest, tax, depreciation and amortization (EBITDA) decreased 17% YoY to Rs 290 crore. The EBITDA margins dropped by ...
27 Jan, 2022, 04.40 PM IST
Laurus Labs inks pact with MPP to produce molnupiravir"We are happy to sign an agreement to manufacture the oral COVID-19 antirviral medication, which is an urgent need of the hour, this is one...
21 Jan, 2022, 11.52 AM IST
Indian drugmaker Laurus Labs with 350% stock gain seeks to boost capacityThe pharmaceutical sector is the top performer in India’s $2.1 trillion equity market this year after the coronavirus pandemic turned globa...
30 Oct, 2020, 06.04 PM IST
Lauras Labs’ Q2 net up 1% on higher capexFor the quarter ended September 2017, the company posted a 4.3% growth in its revenues to Rs 538.6 crore as against Rs 516.5 crore in the c...
10 Nov, 2017, 09.49 PM IST
Citi bullish on Laurus; return ratios will improve post formulations: Satyanarayana Chava, Founder & CEOOnce the formulation business starts giving revenues, our gross margin in that business is straight away over PPT, says Satyanarayana Chava...
27 Mar, 2017, 10.59 AM IST
Profits will grow significantly, exciting times lay ahead: Satyanarayana Chava, Laurus LabsThere are many facilities which have been inaugurated but are not giving any revenue. Once they start giving revenue, the company will have...
19 Dec, 2016, 12.52 PM IST
ISB Alumni contributing towards the institution's growthThe connect between ISB and its alumni community is getting stronger every year with more alumni coming back to School to contribute in the...
22 Jul, 2015, 04.41 PM IST
Carlyle Group, Advent International in race for Rs 900 crore stake in Laurus LabsPE giant Carlyle Group and Advent International are in discussions for a $150-million (Rs 900-crore) investment deal in Laurus Labs.
11 Feb, 2014, 11.02 AM IST
- S3V to set up a Rs 140 crore facility for medical devices
S3V Vascular Technologies floated by four graduates of the ISB said it would set up a Rs 140 crore facility to develop products in Interven...
06 Dec, 2011, 10.52 PM IST